Don't Miss Out

Subscribe to OCA's News & Alerts.

Glutathione D-day: June 8

The FDA is once again threatening personalized medicines, this time glutathione, a crucial antioxidant. Action Alert!

Your ability to use personalized glutathione, an antioxidant that is essential to life, is in jeopardy. An FDA committee that has already voted to ban many natural medicines is meeting soon (June 8th) to decide whether compounding pharmacies can continue to make glutathione in any form, including IVs, inhaled forms, suppositories, and nasal sprays. Glutathione helps patients with a wide variety of ailments, including liver disease, cancer, stroke, and autism. We must let the FDA and the committee know that patients need this treatment.

A glutathione ban would be a disaster. It has many medical applications and there is no commercially available glutathione drug, so a ban would mean no more glutathione in these forms. Glutathione is used widely by integrative experts for a variety of conditions because of its role in reducing oxidative stress—an imbalance between free radicals and antioxidants in the body.